IBDEI34V ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50042,1,3,0)
 ;;=3^Atopic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,50042,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,50042,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,50043,0)
 ;;=L20.9^^193^2487^87
 ;;^UTILITY(U,$J,358.3,50043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50043,1,3,0)
 ;;=3^Atopic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,50043,1,4,0)
 ;;=4^L20.9
 ;;^UTILITY(U,$J,358.3,50043,2)
 ;;=^5009113
 ;;^UTILITY(U,$J,358.3,50044,0)
 ;;=L21.8^^193^2487^302
 ;;^UTILITY(U,$J,358.3,50044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50044,1,3,0)
 ;;=3^Seborrheic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,50044,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,50044,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,50045,0)
 ;;=L21.9^^193^2487^303
 ;;^UTILITY(U,$J,358.3,50045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50045,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,50045,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,50045,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,50046,0)
 ;;=L23.7^^193^2487^31
 ;;^UTILITY(U,$J,358.3,50046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50046,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,50046,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,50046,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,50047,0)
 ;;=L23.9^^193^2487^32
 ;;^UTILITY(U,$J,358.3,50047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50047,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,50047,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,50047,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,50048,0)
 ;;=L24.9^^193^2487^166
 ;;^UTILITY(U,$J,358.3,50048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50048,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,50048,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,50048,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,50049,0)
 ;;=L25.9^^193^2487^117
 ;;^UTILITY(U,$J,358.3,50049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50049,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,50049,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,50049,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,50050,0)
 ;;=L26.^^193^2487^151
 ;;^UTILITY(U,$J,358.3,50050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50050,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,50050,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,50050,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,50051,0)
 ;;=L27.0^^193^2487^305
 ;;^UTILITY(U,$J,358.3,50051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50051,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,50051,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,50051,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,50052,0)
 ;;=L27.1^^193^2487^306
 ;;^UTILITY(U,$J,358.3,50052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50052,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,50052,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,50052,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,50053,0)
 ;;=L29.0^^193^2487^290
 ;;^UTILITY(U,$J,358.3,50053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50053,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,50053,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,50053,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,50054,0)
 ;;=L29.9^^193^2487^291
 ;;^UTILITY(U,$J,358.3,50054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50054,1,3,0)
 ;;=3^Pruritus,Unspec
